$437 Million All-Cash Deal: Knox Lane to Acquire Cross Country Healthcare
CCRN sits 36% above its 52-week low of $7.43.
Summary
Knox Lane has announced an all-cash acquisition of Cross Country Healthcare (CCRN) for $437 million. This definitive agreement provides a significant premium for CCRN shareholders, especially considering the company's recent financial performance, which included a reported net loss of $94.9 million and a 21.6% revenue decline in its 2025 10-K. The acquisition offers a clear exit strategy and will likely drive CCRN's stock price towards the offer value. Traders should monitor the closing conditions, regulatory approvals, and any potential for competing bids.
At the time of this announcement, CCRN was trading at $10.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $326.7M. The 52-week trading range was $7.43 to $14.99. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.